Trial Profile
Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes Inadequately Controlled With D150 Plus D745 10mg: Multi-center, Randomized, Double-blind, Parallel-group, Placebo Control, Therapeutic Confirmatory Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Lobeglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Chong Kun Dang
- 24 Aug 2021 Status changed from active, no longer recruiting to completed.
- 28 Jan 2020 Status changed from recruiting to active, no longer recruiting.
- 19 Nov 2018 New trial record